Introduction:
Severe Acute Respiratory Syndrome -Coronavirus 2 (SARS-COV2) was responsible for the latest outbreak recently, presenting as mainly respiratory symptoms and carrying high mortality rate[1]. COVID-19 put all people at risk of being infected including haemoglobinopathies patients. Multiple factors among those patients increase their risk for infections yet the occurrence of reinfection and it is implication on them, and the community were not described before. Thalassemia is one of the most common haemoglobinopathies and requires life-long management and follow up. Splenectomy, regular blood transfusion and iron chelation therapy are essential components in the management plan. Unfortunately, they cause some complications on the long term and might raise the slurpability of current reinfection[2]. The impact of these factors on COVID-19 infection is not well known yet.
Here we present a case of 31-year-old splenectomized lady with transfusion dependent Beta Thalassemia Major had COVID-19 infection recurrence detected by screening. In this article we are discussing the possibility behind COVID-19 reinfection in thalassemia patients.